Viemed Healthcare, Inc. (VMD) News
Follow Viemed Healthcare, Inc. (VMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
VMD Q3'26 Results Preview: Revenue Estimate
Viemed Healthcare is scheduled to report Q3'26 results on November 4 at 7:00 a.m. ET. Revenue and EPS estimates were provided.
EQUITY | Oct 28, 2026, 11:04 AM UTC
L
Viemed Healthcare, Inc. (VMD) President Sets 10b5-1 Plan to Sell Up to 246K Shares
Viemed Healthcare, Inc. said President Michael Moore adopted a Rule 10b5-1 ASDP to sell up to 246,000 shares over ~1 year ending Nov. 30, 2027, with sales starting as early as Dec. 24, 2026 and subject to a minimum floor
EQUITY | Sep 24, 2026, 10:32 PM UTC
L
Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
LAFAYETTE, LA / / September 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") NASDAQ:VMD, a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today anno
NEWS | Sep 24, 2026, 10:31 PM UTC
L
VMD: Strong organic growth, service diversification, and stable financials drive continued expansion
VMD: Strong organic growth, service diversification, and stable financials drive continued expansion
EQUITY | Aug 26, 2026, 11:04 PM UTC
L
VMD: Strong organic growth, diversification, and stable financials drive expansion in home healthcare
VMD: Strong organic growth, diversification, and stable financials drive expansion in home healthcare
EQUITY | Aug 26, 2026, 10:40 PM UTC
L
Barrington Research initiates VMD at Outperform, $14.00 target
Barrington Research initiates VMD with an Outperform rating and a $14.00 price target; no catalyst was supplied.
EQUITY | Aug 24, 2026, 11:59 AM UTC
L
Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est
Viemed Healthcare (NASDAQ: VMD ) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate.
EARNINGS | Aug 03, 2026, 09:03 PM UTC